128 related articles for article (PubMed ID: 26971631)
1. Review on the binding of anticancer drug doxorubicin with DNA and tRNA: Structural models and antitumor activity.
Agudelo D; Bourassa P; Bérubé G; Tajmir-Riahi HA
J Photochem Photobiol B; 2016 May; 158():274-9. PubMed ID: 26971631
[TBL] [Abstract][Full Text] [Related]
2. Intercalation of antitumor drug doxorubicin and its analogue by DNA duplex: structural features and biological implications.
Agudelo D; Bourassa P; Bérubé G; Tajmir-Riahi HA
Int J Biol Macromol; 2014 May; 66():144-50. PubMed ID: 24560949
[TBL] [Abstract][Full Text] [Related]
3. tRNA binding to antitumor drug doxorubicin and its analogue.
Agudelo D; Bourassa P; Beauregard M; Bérubé G; Tajmir-Riahi HA
PLoS One; 2013; 8(7):e69248. PubMed ID: 23922696
[TBL] [Abstract][Full Text] [Related]
4. Folic acid binds DNA and RNA at different locations.
Bourassa P; Tajmir-Riahi HA
Int J Biol Macromol; 2015 Mar; 74():337-42. PubMed ID: 25555838
[TBL] [Abstract][Full Text] [Related]
5. Characterization of doxorubicin binding site and drug induced alteration in the functionally important structural state of oxyhemoglobin.
Khan SN; Islam B; Yennamalli R; Zia Q; Subbarao N; Khan AU
J Pharm Biomed Anal; 2008 Dec; 48(4):1096-104. PubMed ID: 18842373
[TBL] [Abstract][Full Text] [Related]
6. Structural modeling for DNA binding to antioxidants resveratrol, genistein and curcumin.
N'soukpoé-Kossi CN; Bourassa P; Mandeville JS; Bekale L; Tajmir-Riahi HA
J Photochem Photobiol B; 2015 Oct; 151():69-75. PubMed ID: 26188387
[TBL] [Abstract][Full Text] [Related]
7. Increasing DNA binding affinity of doxorubicin by loading on Fe
Mirzaei-Kalar Z; Yavari A; Jouyban A
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Mar; 229():117985. PubMed ID: 31901801
[TBL] [Abstract][Full Text] [Related]
8. Interaction of antioxidant flavonoids with tRNA: intercalation or external binding and comparison with flavonoid-DNA adducts.
Kanakis CD; Tarantilis PA; Polissiou MG; Tajmir-Riahi HA
DNA Cell Biol; 2006 Feb; 25(2):116-23. PubMed ID: 16460235
[TBL] [Abstract][Full Text] [Related]
9. Transfer RNA bindings to antitumor estradiol-platinum(II) hybrid and cisplatin.
N'soukpoé-Kossi CN; Descôteaux C; Asselin E; Bariyanga J; Tajmir-Riahi HA; Bérubé G
DNA Cell Biol; 2008 Jun; 27(6):337-43. PubMed ID: 18447754
[TBL] [Abstract][Full Text] [Related]
10. Encapsulation of antitumor drug Doxorubicin and its analogue by chitosan nanoparticles.
Sanyakamdhorn S; Agudelo D; Tajmir-Riahi HA
Biomacromolecules; 2013 Feb; 14(2):557-63. PubMed ID: 23305154
[TBL] [Abstract][Full Text] [Related]
11. Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin.
Talelli M; Iman M; Varkouhi AK; Rijcken CJ; Schiffelers RM; Etrych T; Ulbrich K; van Nostrum CF; Lammers T; Storm G; Hennink WE
Biomaterials; 2010 Oct; 31(30):7797-804. PubMed ID: 20673684
[TBL] [Abstract][Full Text] [Related]
12. Constructing transferrin receptor targeted drug delivery system by using doxorubicin hydrochloride and vanadocene dichloride.
Zhang Y; Xiang J; Liu Y; Zhang X; Tang Y
Bioorg Med Chem Lett; 2011 Oct; 21(19):5982-6. PubMed ID: 21862329
[TBL] [Abstract][Full Text] [Related]
13. Breast anticancer drug tamoxifen and its metabolites bind tRNA at multiple sites.
Bourassa P; Thomas TJ; Bariyanga J; Tajmir-Riahi HA
Int J Biol Macromol; 2015 Jan; 72():692-8. PubMed ID: 25263468
[TBL] [Abstract][Full Text] [Related]
14. Interaction of doxorubicin with a regulatory element of hmga1 and its in vitro anti-cancer activity associated with decreased HMGA1 expression.
Akhter MZ; Rajeswari MR
J Photochem Photobiol B; 2014 Dec; 141():36-46. PubMed ID: 25313540
[TBL] [Abstract][Full Text] [Related]
15. Structural-conformational aspects of tRNA complexation with chloroethyl nitrosourea derivatives: A molecular modeling and spectroscopic investigation.
Agarwal S; Tyagi G; Chadha D; Mehrotra R
J Photochem Photobiol B; 2017 Jan; 166():1-11. PubMed ID: 27838504
[TBL] [Abstract][Full Text] [Related]
16. Spectral analysis of doxorubicin accumulation and the indirect quantification of its DNA intercalation.
Hovorka O; Subr V; Větvička D; Kovář L; Strohalm J; Strohalm M; Benda A; Hof M; Ulbrich K; Ríhová B
Eur J Pharm Biopharm; 2010 Nov; 76(3):514-24. PubMed ID: 20638475
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of the calicheamicin gamma 1I-DNA complex.
Kumar RA; Ikemoto N; Patel DJ
J Mol Biol; 1997 Jan; 265(2):187-201. PubMed ID: 9020982
[TBL] [Abstract][Full Text] [Related]
18. Solution structure of the esperamicin A1-DNA complex.
Kumar RA; Ikemoto N; Patel DJ
J Mol Biol; 1997 Jan; 265(2):173-86. PubMed ID: 9020981
[TBL] [Abstract][Full Text] [Related]
19. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
[TBL] [Abstract][Full Text] [Related]
20. Influence of a magnetic nanoparticle as a drug carrier on the activity of anticancer drugs: interactions of double stranded DNA and doxorubicin modified with a carrier.
Nowicka AM; Kowalczyk A; Donten M; Krysinski P; Stojek Z
Anal Chem; 2009 Sep; 81(17):7474-83. PubMed ID: 19663451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
